Aurinia Pharmaceuticals, Inc. (AUPH)
16.58
-0.07
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals EPS Diluted (Quarterly) : 0.2802 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2802 |
| March 31, 2026 | 0.2496 |
| December 31, 2025 | 1.526 |
| September 30, 2025 | 0.232 |
| June 30, 2025 | 0.1564 |
| March 31, 2025 | 0.163 |
| December 31, 2024 | 0.0097 |
| September 30, 2024 | 0.0985 |
| June 30, 2024 | 0.005 |
| March 31, 2024 | -0.0746 |
| December 31, 2023 | -0.1868 |
| September 30, 2023 | -0.0941 |
| June 30, 2023 | -0.0805 |
| March 31, 2023 | -0.1837 |
| December 31, 2022 | -0.1831 |
| September 30, 2022 | -0.0634 |
| June 30, 2022 | -0.2506 |
| March 31, 2022 | -0.2656 |
| December 31, 2021 | -0.25 |
| September 30, 2021 | -0.3913 |
| June 30, 2021 | -0.3666 |
| March 31, 2021 | -0.3954 |
| December 31, 2020 | -0.0637 |
| September 30, 2020 | -0.3443 |
| June 30, 2020 | -0.2358 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2311 |
| December 31, 2019 | -0.7808 |
| September 30, 2019 | -0.2065 |
| June 30, 2019 | -0.1733 |
| March 31, 2019 | -0.1379 |
| December 31, 2018 | -0.1709 |
| September 30, 2018 | -0.215 |
| June 30, 2018 | -0.19 |
| March 31, 2018 | -0.18 |
| December 31, 2017 | -0.0396 |
| September 30, 2017 | -0.16 |
| June 30, 2017 | -0.03 |
| March 31, 2017 | -0.92 |
| December 31, 2016 | -0.21 |
| September 30, 2016 | -0.21 |
| June 30, 2016 | -0.10 |
| March 31, 2016 | -0.13 |
| December 31, 2015 | -0.13 |
| September 30, 2015 | -0.16 |
| June 30, 2015 | -0.02 |
| March 31, 2015 | -0.27 |
| December 31, 2014 | -0.15 |
| September 30, 2014 | -0.08 |
| June 30, 2014 | -0.35 |
| March 31, 2014 | -0.24 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | -0.4335 |
| Medicus Pharma Ltd. | -0.1524 |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | -1.112 |
| Psyence Biomedical Ltd. | -3.178 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 37.41M |
| Revenue (Quarterly) | 83.22M |
| Total Expenses (Quarterly) | 45.81M |
| Enterprise Value | 1.834B |
| Gross Profit Margin (Quarterly) | 92.12% |
| Profit Margin (Quarterly) | 44.96% |
| Earnings Yield | 13.80% |
| Operating Earnings Yield | 6.22% |
| Normalized Earnings Yield | 13.80 |